TRIPEPTIDES AS ASYMMETRIC ORGANOCATALYST
determined by chiral HPLC (ChiralCel OD-H, iPrOH/n-hexane
10/90, flow rate= 1 mL/min, λ = 254 nm), tmajor = 15.172 min,
tminor = 17.852 min, ee = 81%, dr= 98:2 (anti/syn)
(R)-2-((S)-(4-chlorophenyl)(hydroxy)methyl)cyclohexanone
4a.
FT-IR (cm-1): 2828, 2663, 2552, 1678, 1418, 1284, 926; 1H NMR
(500 MHz, CDCl3): δ (ppm) = 1.25–1.27 (m, 2H), 1.52–1.55
(m, 2H), 1.56–1.60 (m, 1H), 1.60–1.63 (m, 1H), 2.07-2.08 (m,
1H), 2.31-2.37 (td, J = 13.7 Hz, J = 6.8 Hz, 1H), 2.46-2.53 (m,
Scheme 2. Aldol reaction catalyzed by peptide 1.
1H),
2.54-2.55 (m, 1H), 4.76 (d, J = 9.15 Hz, 1H), 7.25
(d, J = 9.15 Hz, 2H), 7.32 (d, J = 9.15 Hz, 2H). 13C NMR
(100 MHz, CDCl3) δ = 24.68, 27.71, 30.74, 42.65, 57.34,
74.13, 128.36, 128.52, 130.16, 133.58, 133.66, 139.43,
TABLE 1. Effect of the solvent ratio on the catalytic aldol
reaction between cyclohexanone and p-nitrobenzaldehydes
catalyzed by 1a
and 135 deg
215.37. DEPT90
demonstrate four methylene
groups (negative) and 6 methine groups (positive). MS
(DI) = 238. Yield: 96%. The ee of the product was deter-
i
mined by chiral HPLC (ChiralCel OD-H, PrOH/n-hexane
5/95, flow rate = 0.5 mL/min, λ = 254 nm): tmajor = 22.316
min, tminor = 29.783 min, ee = 86%, dr = 93:7 (anti/syn).
2-((S)-(4-(trifluoromethyl)phenyl)(hydroxy)methyl)cyclohexa-
none 5a. FT-IR (cm-1): 3065, 2828, 2663, 2552, 1678, 1418,
1
1285, 928; H NMR (500 MHz, CDCl3): δ (ppm) = 1.18–1.21
(m, 2H),
1.47–1.49 (m, 2H), 1.49-1.52 (m, 1H), 1.53–1.61
(m, 1H), 2.02- 2.04 (m, 1H), 2.28–2.32 (td, J = 5.7 Hz,
J = 13.7 Hz, 1H), 2.40-2.43 (m, 1H), 2.50-2.52 (m, 1H), 4.77
(d, J = 8 Hz, 1H), 7.37 (d, J = 8 Hz, 2H), 7.53 (d, J = 8 Hz, 2H).
13C NMR (100 MHz, CDCl3) δ = 24.70, 27.68, 30.74, 42.66,
57.24, 74.27, 122.99, 125.28, 125.32, 126.05, 127.34, 129.96,
144.93, 215.10. DEPT90 and 135 deg demonstrate four methy-
lene groups (negative) and six methine groups (positive).
MS(DI) = 272. Yield: 97%. The ee was determined by chiral
Entry
Water (ml)
iPrOH (ml)
Yieldb [%]
eec [anti](%)
1
2
3
4
5
6
7
8
9
10
0
1
70
72
77
80
85
92
93
90
82
69
65
70
73
73
76
78
81
80
72
70
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
i
HPLC (Chiral OD-H, PrOH/n-hexane 10/90, flow rate = 0.5
mL/min, λ = 254 nm): tmajor = 23.901 min, tminor = 32.114
min, ee = 70%, dr = 90 : 10 (anti/syn).
2-((S)-(4-bromophenyl)(hydroxy)methyl)cyclohexanone
6a.
FT-IR (cm-1): 2941, 2833, 2659, 2550, 1678, 1415, 1281,
925; 1H NMR (500 MHz, CDCl3): δ (ppm) = 1.25–1.32
(m, 1H), 1.49–1.69 (m, 4H), 1.71–1.85 (m, 1H), 2.06–2.10
(m, 1H), 2.31–2.39 (td, J = 13.7 Hz, J = 5.7 Hz, 1H), 2.43–2.48
(m, 1H), 2,52–2.57 (m, 1H), 4.74 (d, J = 9.2 Hz, 1H), 7.19 (d,
J = 8 Hz, 2H), 7.46 (d, J = 8 Hz, 2H). 13C NMR (100 MHz,
CDCl3) δ = 24.67, 27.69, 30.73, 42.64, 57.28, 74.18, 121.70,
127.50, 128.71, 130.14, 131.47, 139.93, 215.33. DEPT90 and
aReaction condition: p-nitrobenzaldehyde (30 mg, 0.198 mmol, 1 eq), cyclohexa-
none (23.3 mg, 0.238 mmol, 1.2 eq), NMM (pH = 5–5.5) , solvents at RT within 24 h.
bIsolated yield.
cDetermined by HPLC on CHIRALCEL OD-H column.
1H), 7.26–7.31 (m, 2H), 7.52 (dd, J = 8, J = 2.3Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ = 24.84, 27.76, 30.35, 42.66, 57.52, 70.40,
127.19, 128.19, 128.70, 129.16, 132.91, 139.00, 215.26. DEPT90
and135degdemonstratefourmethylenegroups(negative)andsix
methine groups (positive). MS(DI) = 238. Yield: 97%. The ee of
the product was determined by chiral HPLC (ChiralCel OD-H,
iPrOH/n-hexane 10/90, flow rate = 1.3 mL/min, λ = 254 nm),
tmajor = 8.670 min, tminor = 10.822 min, ee = 88%, dr = 99/1
(anti/syn).
135 deg
demonstrate four methylene groups (negative) and
six methine groups (positive). MS(DI) = 282. Yield: 96%.
The ee was determined by chiral HPLC (Chiral OD-H,
iPrOH/n-hexane 10/90, flow rate = 1 mL/min, λ = 254 nm):
tmajor = 12.366 min, tminor = 15.775 min, ee = 78%, dr = 75: 25
(anti/syn).
2-[Hydroxy-(4-cyano-phenyl)-methyl]-cyclohexanone 7a. FT-IR
(R)-2-((S)-hydroxy(2-nitrophenyl)methyl)cyclohexanone 3a. FT-IR
(cm-1): 3411, 2942, 2866, 1703, 1524, 1349; 1H NMR
(500 MHz, CDCl3): δ (ppm) = 1.53–1.75(m, 5H), 1.80–1.85 (m,
1H), 2.05–2.11 (m, 1H), 2.28–2.35 (td, J = 13.75 Hz, J = 7 Hz,
1H), 2.40–2.45 (m, 1H), 5.42 (d, J = 6.85 Hz, 1H), 7.40 (t,
J = 8 Hz, 1H), 7.61 (t, J = 6.9 Hz, 1H), 7.74 (d, J = 8 Hz, 1H), 7.82
(d, J = 6.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 24.96,
27.74, 31.11, 42.81, 57.27, 69.77, 124.08, 128.39, 128.97, 133.07,
136.58, 148.69, 215.02. DEPT90 and 135 deg demonstrate four
methylene groups (negative) and six methine groups (posi-
tive). MS(DI)= 249. Yield: 96%. The ee of the product was
(cm-1): 3425, 3356, 2932, 2860, 1688, 1481, 1053, 824; 1H
NMR (500 MHz, CDCl3):
1.62–1.71 (m, 3H), 1.89–1.99 (m, 2H), 2.06–2.12 (m,
1H), 2.29–2.35 (m, 1H), 4.75 (d, J = 9.15 Hz, 1H), 5.31
δ (ppm) = 1.43–1.54(m, 1H),
(d, J = 2.3 Hz, 1H) 7.41 (d, J = 8 Hz, 2H), 7.58 (d,
J = 8 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ = 20.25,
22.24, 26.66, 38.94, 55.97, 74.43, 110.82, 118.71, 126.19,
127.17, 132.11, 148.30, 219.91. DEPT90 and 135 deg demon-
strate four methylene groups (negative) and six methine
groups (positive). MS(DI) = 229. Yield: 95%. The ee of
the product was determined by chiral HPLC (ChiralCel
Chirality DOI 10.1002/chir